CLDI Earnings

Quarterly EPS
$-124.00
Q3 2024
$-28.74
Q4 2024
$-35.36
Q1 2025
$-31.75
Q2 2025
$-35.36
Q3 2025
$-6.58
Q4 2025
$-6.88
Q1 2026
$-2.94
Q2 2026
Latest RevenueN/A
Latest Net Income-4160000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.940-4160000+90.7%
Q1 2026-$6.880-4108000+80.5%
Q4 2025-$6.580-4059000+77.1%
Q3 2025-$35.360-5181000+71.5%
Q2 2025-$31.750-5761000+88.2%
Q1 2025-$35.360-5062000+90.9%
Q4 2024-$28.740-4148000+89.7%
Q3 2024-$124.000-5069000+54.2%
Q2 2024-$268.000-5767000
Q1 2024-$389.760-7225000
Q4 2023-$279.230-8229000
Q3 2023-$270.720-2024000
Calidi Biotherapeutics (CLDI) — Earnings